Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tetyana, Denyssevych"'
Autor:
Linda Hamata, Tetyana Denyssevych, Brian Thiessen, Dawn Waterhouse, Sarah Jennings, Shirin Monfared, Sharon Smith, Mário L de Lemos
Publikováno v:
Journal of Oncology Pharmacy Practice. 15:45-52
Background. Neurotoxicity of intrathecal (IT) chemotherapy has been variously attributed to the preservatives, volume, osmolality, and pH of the preparations. There has been little evaluation of how different drug concentrations or diluents can affec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43088d4b603280cb200030ef38ea0120
https://doi.org/10.1177/1078155208096902
https://doi.org/10.1177/1078155208096902
Autor:
Tetyana Denyssevych, Marcel B. Bally, Karen A. Gelmon, Hong Yan, Dana Masin, Corinna Warburton, Wieslawa H. Dragowska, Anne E. Wallis, Stephen Chia
Publikováno v:
Clinical Cancer Research. 10:2512-2524
Purpose: The purpose of this research was to assess the effects of single agent and combination treatment with trastuzumab and gefitinib on tumor growth and tumor microenvironment in two HER-2/neu overexpressing breast xenograft models, MDA-MB-435/LC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7876e8260d3290e522c4b1cbdd16c589
https://doi.org/10.1158/1078-0432.ccr-03-0244
https://doi.org/10.1158/1078-0432.ccr-03-0244
Autor:
Karen A. Gelmon, Marcel B. Bally, Tetyana Denyssevych, Stephen Chia, Norma Hudon, Dawn Waterhouse
Publikováno v:
Pharmaceutical research. 22(6)
We assessed the combination of doxorubicin or liposomal doxorubicin with trastuzumab for alterations in peak serum drug levels, as these agents are increasingly being paired in the treatment of aggressive breast cancer. We hypothesized that trastuzum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3f069a53b33e9b58235e3164516869
https://pubmed.ncbi.nlm.nih.gov/15948035
https://pubmed.ncbi.nlm.nih.gov/15948035
Autor:
Corinna, Warburton, Wieslawa H, Dragowska, Karen, Gelmon, Stephen, Chia, Hong, Yan, Dana, Masin, Tetyana, Denyssevych, Anne E, Wallis, Marcel B, Bally
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(7)
The purpose of this research was to assess the effects of single agent and combination treatment with trastuzumab and gefitinib on tumor growth and tumor microenvironment in two HER-2/neu overexpressing breast xenograft models, MDA-MB-435/LCC6(HER-2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9469f5ab2690a4b5ba5a069d9927b7c
https://pubmed.ncbi.nlm.nih.gov/15073131
https://pubmed.ncbi.nlm.nih.gov/15073131
Publikováno v:
European journal of drug metabolism and pharmacokinetics. 27(2)
The MDR modulator, OC144-093, is a potential candidate for use in cancer therapy and exhibits potent biological activity in vitro and in vivo when combined with anticancer agents such as paclitaxel. Its inhibitory interaction with P-glycoprotein (Pgp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c35cfd94a4de453263c48c4db20c451
https://pubmed.ncbi.nlm.nih.gov/12064370
https://pubmed.ncbi.nlm.nih.gov/12064370
Autor:
Dawn N. Waterhouse, Tetyana Denyssevych, Norma Hudon, Stephen Chia, Karen A. Gelmon, Marcel B. Bally
Publikováno v:
Pharmaceutical Research; Jun2005, Vol. 22 Issue 6, p915-922, 8p